Quest Diagnostics (DGX) Tops Q4 EPS by 24c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

February 4, 2021 6:48 AM EST

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $4.48, $0.24 better than the analyst estimate of $4.24. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.93 billion.

Outlook for First Half of 2021

The company estimates its first half 2021 results as follows:

Low

High

Net revenues

$4.85 billion

$5.15 billion

Net revenues increase

32.9%

41.1%

Reported diluted EPS

$5.07

6.07

Adjusted diluted EPS

$5.90

$6.90

Cash provided by operations

At least $800 million

Capital expenditures

Approximately $200 million

Note on Non-GAAP Financial Measures

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings